Kilitch Drugs (India) Ltd share price logo

Kilitch Drugs (India) Ltd

NSE: KILITCH

BSE: 524500

Small Cap

Pharma Sector

₹172.73

+5.84

(+3.50%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Kilitch Drugs (India) Stock Performance

as on August 25, 2026 at 6:02 pm IST

  • Day's Low

    Day's High

    ₹164.40
    ₹175.10
    downward going graph

    4.82%

    Downside

    1.37%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹117.25
    ₹219.50
    downward going graph

    32.12%

    Downside

    27.08%

    Upside

    downward going graph

Kilitch Drugs (India) share price movements today

Previous Close
₹166.89
Open
₹168.30
Volume
24.15K
Upper Circuit
₹175.23
Lower Circuit
₹158.55
Day's Low - High
₹164.40 - ₹175.10
52 Week Low - High
₹117.25 - ₹219.50

Kilitch Drugs (India) Historical Returns

1 Month Return
-7.72 %
3 Month Return
-9.88 %
1 Year Return
-56.89 %
3 Year Return
-11.42 %
5 Year Return
-2.35 %

Kilitch Drugs (India) Fundamentals

as on August 25, 2026 at 12:32 pm IST

Market Cap

₹583.47 Cr

Return on Equity (ROE)

11.06

PE Ratio (TTM)

0

Return on capital employed (ROCE)

12.35

Industry PE ratio

-

Beta (LTM)

1.17

P/B Ratio

1.34

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-12.83

EPS (TTM)

8.44

Book Value

79.99

Kilitch Drugs (India) Technical Analysis

Track how Kilitch Drugs (India) technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish7
Bullish5
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.19
Bullish
CCI (20)
-23.03
Neutral
RSI (14)
6.2
Bullish
Momentum (10)
0
Neutral
ADI (14)
75.63
Neutral
Ultimate Oscillator (7,14,28)
70.24
Bullish

Moving Averages

Name

Value

Action

SMA (20)
172.18
Bearish
EMA (20)
172.18
Bearish
VWMA (20)
172.05
Bearish
SMA (50)
172.6
Bearish
EMA (50)
172.37
Bearish
SMA (200)
169.83
Bullish
EMA (200)
170.53
Bullish
KAMA (200)
172
Bearish
DEMA (200)
172.87
Bearish

Kilitch Drugs (India) Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kilitch Drugs (India) with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
NA583.47-0.47%0.6229235
Alivus Life Sciences Ltd image
Alivus Life Sciences Ltd
BUY16,771.8120.45%0.005642,551
Parmax Pharma Ltd image
Parmax Pharma Ltd
NA49.0752.96%0.00-328
Parnax Lab Ltd image
Parnax Lab Ltd
NA142.2182.12%0.7311187
ERIS Lifesciences Ltd image
ERIS Lifesciences Ltd
BUY18,370.6016.13%0.763742,908
See all

Kilitch Drugs (India) Stock’s Investor Sentiment and Interest

Search interest for Kilitch Drugs (India) Ltd Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

Kilitch Drugs (India) Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
41.2
31.79
44.82
33.45
47.47
56.17
61.23
43.14
48.92
53.81
89.6
44.88
Other Income
0.49
2.96
0.47
2.57
5.16
1.73
1.7
2.56
6.66
1.53
0.49
2.9
Total Income
41.69
34.75
45.29
36.03
52.64
57.89
62.92
45.7
55.58
55.34
90.1
47.78
Expenses
32.58
29.51
37.74
31.79
41.38
47.43
46.63
39.88
43.88
47.66
67.46
41.94
Operating Profit
8.62
2.28
7.08
1.66
6.09
8.74
14.6
3.26
5.04
6.15
22.14
2.94
Operating Profit Margin %
20.92%
7.17%
15.8%
4.96%
12.83%
15.56%
23.84%
7.56%
10.3%
11.43%
24.71%
6.55%
Profit Before Interest, Tax and Depreciation
9.11
5.24
7.55
4.23
11.26
10.46
16.29
5.82
11.7
7.68
22.64
5.83
Interest
1.51
1.6
1.32
1.73
0.31
1.4
1.6
1.53
1.44
1.15
1.44
0.88
Depreciation
0.82
0.81
0.93
0.85
0.61
0.81
0.85
0.84
0.86
0.94
0.98
1.09
Profit Before Tax
6.78
2.83
5.3
1.65
10.34
8.25
13.84
3.45
9.4
5.59
20.22
3.86
Tax Paid
1.69
1.08
1.62
1.54
1.73
2.64
3.63
1.19
1.36
1.28
5.33
1.89
Profit After Tax
5.09
1.74
3.68
0.11
8.61
5.61
10.22
2.26
8.04
4.32
14.88
1.97
Total Net profit including share of profit / Loss from associate company
5.09
1.74
3.68
0.11
8.61
5.61
10.22
2.26
8.04
4.32
14.88
1.97
EPS
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
2.5
4.24
0.83
Actual EPS
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
2.5
4.24
0.83
Adjusted EPS
1.43
0.91
1.1
0.41
2.62
1.82
3.17
0.92
2.49
1.25
4.24
0.83
Diluted EPS
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
2.5
4.24
0.83

Kilitch Drugs (India) Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
51.01
82.49
53.32
68.52
114.23
139.6
154.37
198.32
235.47
Other Income
2.88
4
4.13
2.67
2.91
2.92
4.48
11.16
11.24
Total Income
53.89
86.49
57.45
71.19
117.14
142.52
158.85
209.48
246.71
Expenses
45.73
75.48
53.12
63.33
103.87
122.03
130.22
166.85
198.88
Operating Profit
5.28
7.01
0.2
5.19
10.36
17.57
24.15
31.47
36.59
Operating Profit Margin %
10.35%
8.5%
0.38%
7.57%
9.07%
12.59%
15.64%
15.87%
15.54%
Profit Before Interest, Tax and Depreciation
8.16
11.02
4.32
7.86
13.28
20.48
28.63
42.63
47.84
Interest
-
0.38
0.72
0.75
1.2
4.92
5.93
5.04
5.56
Depreciation
2.04
2.05
2
1.99
2.47
3.55
3.35
3.11
3.62
Profit Before Tax
6.12
8.59
1.6
5.12
9.61
12.01
19.35
34.48
38.66
Tax Paid
0.96
4.76
0.77
1.36
3.4
3.73
5.78
9.53
9.16
Profit After Tax
5.15
3.83
0.84
3.77
6.21
8.28
13.58
24.94
29.5
Total Net profit including share of profit / Loss from associate company
5.15
3.83
0.84
3.77
6.21
8.28
13.58
24.94
29.5
EPS
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
8.91
Actual EPS
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
8.91
Adjusted EPS
1.9
1.28
0.27
1.16
2.31
3.28
4.49
8.12
8.91
Diluted EPS
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
8.91

Kilitch Drugs (India) Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
17.23
1.12
1.42
0.29
4.46
45.66
5.78
2.59
-1.53
17.54
23.96
Cash Flow from Investing Activities
23.49
-1.54
-4.45
-13.98
-10.46
-37.57
-15.25
7.91
-8.15
-39.94
-100.44
Cash Flow from Financing Activities
0.12
-0.04
5.51
16.85
0.85
1.61
7.03
-0.72
8.81
13.25
82.46
Net Cash Flow
-2.23
-0.45
2.48
3.17
-5.14
9.7
-2.44
9.78
-0.88
-9.16
5.97

Kilitch Drugs (India) Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
63.77%
63.77%
63.77%
63.77%
FII
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.12%
Public
30.77%
30.77%
30.77%
30.77%
30.76%
30.77%
30.77%
30.76%
36.23%
36.23%
36.22%
36.11%
Total Outstanding Shares
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,74,80,782
1,74,80,782
3,49,61,564
3,49,61,564
Total Shareholders
9,002
9,062
9,525
9,620
9,920
10,139
9,749
10,379
10,929
12,043
11,785
12,627

Kilitch Drugs (India) Corporate Actions

View detailed summary of the earnings and dividend history of Kilitch Drugs (India).

  • Kilitch Drugs (India) Ltd Earnings Results

    Kilitch Drugs (India) Ltd’s net profit fell -3.96% since last year same period to ₹2.91Cr in the Q1 2026-2027. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -79.96% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Kilitch Drugs (India) Ltd Dividends May,2019

    In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 per share on 30 May 2019 - translating a dividend yield of 0.31%.

    Read More about Dividends

Insights on Kilitch Drugs (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.00% to 0.12% in Jun 2026 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 63.77% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 36.0% return, outperforming this stock by 92.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 152.2% return, outperforming this stock by 163.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, KILITCH stock has moved down by -47.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 90.1 Cr → 47.78 Cr (in ₹), with an average decrease of 47.0% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 14.52 Cr → 2.91 Cr (in ₹), with an average decrease of 80.0% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 36.22% to 36.11% in Jun 2026 quarter

About Kilitch Drugs (India) Ltd

Kilitch Drugs India Ltd (KDIL) is a pharmaceutical company that was incorporated in May 1992 and has since gone public in Feb. 1994. They manufactures a range of pharmaceutical products including tablets, capsules, liquid orals, ointments, creams and injectables. They operate two divisions for OTC and ethical drugs, with additional manufacturing plants located in India, Ethiopia, Republic of Yemen and Patalganga Maharashtra, India. KDIL also provides exports for Sudan, Yemen, the Middle East, Miami and some South American countries. In 2011, they introduced a new product BENIN. In 2012, their undertakings located at Paonta Sahib in Himachal Pradesh were sold and transferred, while certain products were transferred to Akorn India Pvt. Ltd. KDIL's range of pharmaceutical services ensures safe and quality solutions for their customers.

Revenue: ₹44.88Cr as on June 2026 (Q1 FY27)
Net Profit: ₹1.97Cr as on June 2026 (Q1 FY27)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
OrganisationKilitch Drugs (India) Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOMukund P Mehta
E-voting on sharesClick here to vote

FAQs

What is Kilitch Drugs (India) share price today?

Kilitch Drugs (India) share price today stands at ₹172.73 as on . Kilitch Drugs (India) share today touched a day high of ₹175.1 and a low of ₹164.4.

What is the 52 week high and 52 week low range for Kilitch Drugs (India) share?

Kilitch Drugs (India) touched a 52 week high of ₹219.5 and a 52 week low of ₹117.25. Kilitch Drugs (India) share price today i.e. is trending at ₹172.73, which is -21.31% down from its 52 week high and 47.32% up from its 52 week low.

What is Kilitch Drugs (India)'s market capitalisation today?

Kilitch Drugs (India) market capitalisation is ₹583.47 Cr as on .

How to buy Kilitch Drugs (India) shares?

To buy Kilitch Drugs (India) shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KILITCH or Kilitch Drugs (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kilitch Drugs (India) shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kilitch Drugs (India) trading volume today?

Kilitch Drugs (India) trading volume is 24.15K as on . This means that 24.15K shares of Kilitch Drugs (India) were bought and sold on the stock market during today's trading session.